E WE thrombin (Aronora)

N/A

Report date: 2025/12/29 20:01:35

Base Information

Drug NameE WE thrombin (Aronora)
Drug Alias NameProCaseWEThrombinWE thrombinEWE-thrombinAB-002
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFibrinogen stimulants
TargetsFibrinogen
Therapy Area/IndicationsThrombosisKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAronora Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAronora Inc
Active IndicationsN/A
Inactive IndicationsThrombosisKidney Failure, Chronic

Other Information

ATC CodeN/A
Related LinksN/A